European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Past deals in Ireland

National University of Ireland, Maynooth

Grant in 2024
Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.

Bluedrop Medical

Venture Round in 2023
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.

Nemysis

Grant in 2023
Nemysis Limited is a specialty pharmaceutical company based in Dublin, Ireland, founded in 2005. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a staged approach to product development. Nemysis manufactures food supplements, medical matrix products, and prescription items, targeting the same conditions across different market segments. Among its innovative offerings are a gastric and trypsin-resistant glutenous product for oral enzymatic therapy aimed at celiac disease patients, as well as an iron supplement designed to minimize gastrointestinal side effects associated with iron supplementation. Additionally, the company is developing a glutenous medical device that effectively destroys gluten, helping to prevent symptoms in individuals with celiac disease and non-celiac gluten sensitivity.

Ostoform

Grant in 2022
Ostoform Limited is a medical device company based in Dublin, Ireland, specializing in products designed to manage skin complications for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform has developed patented technologies aimed at enhancing ostomy skin health. Its flagship products include a mouldable seal that fits securely around the stoma, preventing corrosive output from contacting the skin, and FLOWASSIST, which directs stoma output away from the skin to minimize irritation and swelling. By addressing these significant challenges faced by ostomy patients, Ostoform aims to improve comfort and overall quality of life, positioning itself as a potential leader in the global ostomy care market.

AuriGen Medical

Grant in 2022
AuriGen Medical Limited is an innovative company based in Dublin, Ireland, specializing in electrophysiology and structural heart solutions. Founded in 2016, AuriGen develops advanced left atrial appendage (LAA) implants aimed at addressing the stroke and arrhythmia risks associated with persistent atrial fibrillation (AF). The company targets a significant and growing patient population, particularly those with medication-resistant AF, which affects over three million individuals across the United States and Europe. AuriGen's technology offers a novel trans-septal implant that not only treats AF effectively but also reduces the reliance on anticoagulants and anti-arrhythmic medications. By providing cost-effective treatment options, AuriGen aims to improve patient outcomes while addressing the rising financial burden of managing chronic cardiac conditions in aging populations.

Loci Orthopaedics

Grant in 2022
Loci Orthopaedics Limited, established in 2017 and headquartered in Upper Newcastle, Ireland, specialises in the manufacture of medical instruments, notably the InDx implant. This innovative device is designed to mimic natural thumb joint motions and offers a less invasive surgical solution for patients with arthritis in their thumb base joint, addressing a significant unmet clinical need in orthopaedics.

Loci Orthopaedics

Venture Round in 2022
Loci Orthopaedics Limited, established in 2017 and headquartered in Upper Newcastle, Ireland, specialises in the manufacture of medical instruments, notably the InDx implant. This innovative device is designed to mimic natural thumb joint motions and offers a less invasive surgical solution for patients with arthritis in their thumb base joint, addressing a significant unmet clinical need in orthopaedics.

Bluedrop Medical

Venture Round in 2021
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.

Intelligent Implants

Seed Round in 2021
Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

RemedyBio

Venture Round in 2021
RemedyBio is an immunology-focused discovery and development company located in Dublin, Ireland. The company specializes in creating therapeutics aimed at enhancing immunotherapies for complex and heterogeneous diseases. RemedyBio has pioneered innovative techniques for understanding the immune system, particularly through its advanced discovery technology that accelerates the speed and scale of single-cell analysis. This technology supports next-generation applications in areas such as immuno-oncology, autoimmune diseases, and infectious diseases, ultimately offering the healthcare industry effective therapeutic and diagnostic solutions.

Vivasure Medical

Grant in 2021
Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

Intelligent Implants

Grant in 2021
Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

Contego Sports

Grant in 2021
Contego Sports Limited is a company based in Galway, Ireland, that specializes in the manufacture and sale of innovative head guards for rugby players. Founded in 2014 by Mark and Dr. Sandra Ganly, the company combines expertise in sports equipment design and biomedical engineering to develop advanced protective gear. Their flagship product, the N-Pro head guard, is designed to reduce the incidence and severity of brain injuries by effectively managing head impact energy. Contego Sports distributes its products online, aiming to enhance player safety in contact sports through cutting-edge technology and research-driven design.

Provizio

Seed Round in 2020
Provizio Ltd is a company based in Limerick, Ireland, that specializes in accident prevention technology. Founded in 2019, it focuses on enhancing vehicle safety through an innovative platform that combines proprietary long-range imaging sensors and machine learning. This technology aims to perceive, predict, and prevent automotive accidents in real-time by helping drivers identify hazards, even in challenging weather conditions. By addressing the human error that contributes to the majority of road fatalities, Provizio's solutions are designed to significantly reduce serious injuries and fatalities from road accidents. The company's commitment to safety-first thinking positions it as a transformative force in the automotive safety sector.

SiriusXT

Grant in 2020
SiriusXT Limited is a company that specializes in the development and manufacturing of soft x-ray microscopes, specifically the SXT system. Founded in 2015 and headquartered in Dublin, Ireland, SiriusXT's innovative technology utilizes a vacuum-based laser-produced plasma light source to enable high-resolution imaging of biological samples. The SXT system is designed for researchers in disease research and drug discovery, providing a crucial tool for visualizing the 3D internal structures of cells in their native, fully hydrated state without the need for stains or contrast agents. This capability is essential for understanding disease pathways, protein-drug interactions, and bio-engineering processes. SiriusXT is recognized for offering the world's first high-throughput, benchtop soft x-ray tomography system, allowing users to produce detailed tomographs quickly and efficiently.

RemedyBio

Grant in 2020
RemedyBio is an immunology-focused discovery and development company located in Dublin, Ireland. The company specializes in creating therapeutics aimed at enhancing immunotherapies for complex and heterogeneous diseases. RemedyBio has pioneered innovative techniques for understanding the immune system, particularly through its advanced discovery technology that accelerates the speed and scale of single-cell analysis. This technology supports next-generation applications in areas such as immuno-oncology, autoimmune diseases, and infectious diseases, ultimately offering the healthcare industry effective therapeutic and diagnostic solutions.

SiriusXT

Venture Round in 2020
SiriusXT Limited is a company that specializes in the development and manufacturing of soft x-ray microscopes, specifically the SXT system. Founded in 2015 and headquartered in Dublin, Ireland, SiriusXT's innovative technology utilizes a vacuum-based laser-produced plasma light source to enable high-resolution imaging of biological samples. The SXT system is designed for researchers in disease research and drug discovery, providing a crucial tool for visualizing the 3D internal structures of cells in their native, fully hydrated state without the need for stains or contrast agents. This capability is essential for understanding disease pathways, protein-drug interactions, and bio-engineering processes. SiriusXT is recognized for offering the world's first high-throughput, benchtop soft x-ray tomography system, allowing users to produce detailed tomographs quickly and efficiently.

Geowox

Grant in 2019
Geowox Limited is a company that specializes in AI-powered valuations for the residential real estate sector, primarily serving the Irish and British markets. Established in 2017 and headquartered in Dublin, Ireland, Geowox provides a range of valuation services tailored for both lenders and investors. For lenders, the company facilitates new lead generation, property re-valuation, fraud detection, and alignment with regulatory requirements. Investors benefit from Geowox's capabilities in assessing new business opportunities, analyzing risk, and gaining insights into market trends. Additionally, Geowox automates home valuations through online workflow tools designed for lender websites, providing accredited surveyor sign-off and leveraging machine learning models to deliver fast and reliable property information, including sales comparables and neighborhood insights.

Capri Medical

Venture Round in 2019
Capri Medical Limited is a Galway, Ireland-based company established in 2018 that specializes in the development of neurostimulation devices. Its flagship product, Capri-Stim, targets the chronic post-operative pain market by providing neurostimulation to intercept the patient pathway and prevent percutaneous tissue damage. The company focuses on creating implantable devices designed to stimulate the peripheral nervous system, addressing significant healthcare challenges related to chronic peripheral nerve pain. By leveraging advanced bioelectronics technology, Capri Medical aims to enhance patient comfort while delivering superior technical performance for healthcare providers.

Capri Medical

Grant in 2019
Capri Medical Limited is a Galway, Ireland-based company established in 2018 that specializes in the development of neurostimulation devices. Its flagship product, Capri-Stim, targets the chronic post-operative pain market by providing neurostimulation to intercept the patient pathway and prevent percutaneous tissue damage. The company focuses on creating implantable devices designed to stimulate the peripheral nervous system, addressing significant healthcare challenges related to chronic peripheral nerve pain. By leveraging advanced bioelectronics technology, Capri Medical aims to enhance patient comfort while delivering superior technical performance for healthcare providers.

Bluedrop Medical

Grant in 2019
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.

Geowox

Seed Round in 2019
Geowox Limited is a company that specializes in AI-powered valuations for the residential real estate sector, primarily serving the Irish and British markets. Established in 2017 and headquartered in Dublin, Ireland, Geowox provides a range of valuation services tailored for both lenders and investors. For lenders, the company facilitates new lead generation, property re-valuation, fraud detection, and alignment with regulatory requirements. Investors benefit from Geowox's capabilities in assessing new business opportunities, analyzing risk, and gaining insights into market trends. Additionally, Geowox automates home valuations through online workflow tools designed for lender websites, providing accredited surveyor sign-off and leveraging machine learning models to deliver fast and reliable property information, including sales comparables and neighborhood insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.